Degarelix for treating advanced hormone‐sensitive prostate cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of degarelix compared with standard systemic androgen suppression therapy (in the form of surgical castration, medical castration using GnRH agonists, non‐steroidal or steroidal antiandrogen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Jakob, Joachim J, Schmidt, Stefanie, Kunath, Frank, Meerpohl, Joerg J, Blümle, Anette, Schmucker, Christine, Mayer, Benjamin, Zengerling, Friedemann
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2017
Témata:
Medicine General & Introductory Medical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464394/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012548
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky